机构：[1]Xuanwu Hospital of Capital Medical University, Beijing, China首都医科大学宣武医院[2]The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China
第一作者机构：[1]Xuanwu Hospital of Capital Medical University, Beijing, China[2]The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China
推荐引用方式(GB/T 7714)：
Zhang Yi,Guo Taiyan,You Xia,et al.Association of LRP1B mutants with immune biomarkers in Chinese non-small cell lung cancer patients.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e21060.
APA：
Zhang, Yi,Guo, Taiyan,You, Xia,Zhang, Qin,Duan, Qianqian&Qi, Chuang.(2021).Association of LRP1B mutants with immune biomarkers in Chinese non-small cell lung cancer patients..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Zhang, Yi,et al."Association of LRP1B mutants with immune biomarkers in Chinese non-small cell lung cancer patients.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)
医学